Koninklijke Dsm Nv Stock Beta
Koninklijke DSM NV fundamentals help investors to digest information that contributes to Koninklijke DSM's financial success or failures. It also enables traders to predict the movement of Koninklijke OTC Stock. The fundamental analysis module provides a way to measure Koninklijke DSM's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Koninklijke DSM otc stock.
Koninklijke |
Koninklijke DSM NV OTC Stock Beta Analysis
Koninklijke DSM's Beta is one of the most important measures of equity market volatility. Beta can be thought of as asset elasticity or sensitivity to market. In other words, it is a number that shows the relationship of an equity instrument to the financial market in which this instrument is traded. For example, if Beta of equity is 2, it is expected to significantly outperform market when the market is going up and significantly underperform when the market is going down. Similarly, Beta of 1 indicates that an asset and market will generate similar returns over time.
Current Koninklijke DSM Beta | 0.79 |
Most of Koninklijke DSM's fundamental indicators, such as Beta, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Koninklijke DSM NV is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
In a nutshell, Beta is a measure of individual stock risk relative to the overall volatility of the stock market. and is calculated based on very sound finance theory - Capital Assets Pricing Model (CAPM).However, since Beta is calculated based on historical price movements it may not predict how a firm's stock is going to perform in the future.
CompetitionIn accordance with the recently published financial statements, Koninklijke DSM NV has a Beta of 0.785. This is 9.77% lower than that of the Basic Materials sector and 28.64% lower than that of the Specialty Chemicals industry. The beta for all United States stocks is notably lower than that of the firm.
Koninklijke Beta Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Koninklijke DSM's direct or indirect competition against its Beta to detect undervalued stocks with similar characteristics or determine the otc stocks which would be a good addition to a portfolio. Peer analysis of Koninklijke DSM could also be used in its relative valuation, which is a method of valuing Koninklijke DSM by comparing valuation metrics of similar companies.Koninklijke DSM is currently under evaluation in beta category among its peers.
As returns on the market increase, Koninklijke DSM's returns are expected to increase less than the market. However, during the bear market, the loss of holding Koninklijke DSM is expected to be smaller as well.
Koninklijke Fundamentals
| Return On Equity | 0.12 | |||
| Return On Asset | 0.0402 | |||
| Profit Margin | 0.11 % | |||
| Operating Margin | 0.10 % | |||
| Current Valuation | 24.43 B | |||
| Shares Outstanding | 691.88 M | |||
| Shares Owned By Institutions | 0.15 % | |||
| Price To Earning | 38.86 X | |||
| Price To Book | 2.36 X | |||
| Price To Sales | 2.39 X | |||
| Revenue | 9.2 B | |||
| Gross Profit | 3.16 B | |||
| EBITDA | 1.71 B | |||
| Net Income | 1.68 B | |||
| Cash And Equivalents | 1.63 B | |||
| Cash Per Share | 2.36 X | |||
| Total Debt | 2.84 B | |||
| Debt To Equity | 0.31 % | |||
| Current Ratio | 2.51 X | |||
| Book Value Per Share | 14.09 X | |||
| Cash Flow From Operations | 1.43 B | |||
| Earnings Per Share | 1.59 X | |||
| Price To Earnings To Growth | 2.81 X | |||
| Target Price | 44.0 | |||
| Number Of Employees | 21.76 K | |||
| Beta | 0.79 | |||
| Market Capitalization | 23.42 B | |||
| Total Asset | 16.01 B | |||
| Z Score | 4.2 | |||
| Annual Yield | 0.02 % | |||
| Five Year Return | 1.95 % | |||
| Net Asset | 16.01 B | |||
| Last Dividend Paid | 2.63 |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Check out Your Equity Center to better understand how to build diversified portfolios. Also, note that the market value of any otc stock could be closely tied with the direction of predictive economic indicators such as signals in population. You can also try the Equity Analysis module to research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities.
Other Consideration for investing in Koninklijke OTC Stock
If you are still planning to invest in Koninklijke DSM NV check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Koninklijke DSM's history and understand the potential risks before investing.
| Performance Analysis Check effects of mean-variance optimization against your current asset allocation | |
| Funds Screener Find actively-traded funds from around the world traded on over 30 global exchanges | |
| Portfolio Analyzer Portfolio analysis module that provides access to portfolio diagnostics and optimization engine | |
| Idea Optimizer Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio | |
| USA ETFs Find actively traded Exchange Traded Funds (ETF) in USA | |
| Sectors List of equity sectors categorizing publicly traded companies based on their primary business activities | |
| Premium Stories Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope | |
| FinTech Suite Use AI to screen and filter profitable investment opportunities | |
| Fundamentals Comparison Compare fundamentals across multiple equities to find investing opportunities |